XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Nov. 27, 2011
Nov. 28, 2010
Consolidated net income $ 5,391 $ 4,585
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 2,729 2,602
Stock-based compensation expense 885 962
Tax benefit from stock-based compensation expense (3,378) (1,585)
Increase in receivable from Monsanto for guaranteed termination fee (400) (400)
Deferred taxes (463) 737
Change in investment in non-public company (fair market value) (1,174)  
Accounts receivable, net (7,407) (6,033)
Accounts receivable, related party 139 268
Income taxes receivable 3,554 1,682
Inventories, net (14) (3,637)
Issuance of notes and advances receivable (1,586) (1,565)
Collection of notes and advances receivable 240 637
Prepaid expenses and other current assets 652 1,530
Accounts payable 2,140 4,574
Related party accounts payable 32 (227)
Accrued compensation 304 104
Other accrued liabilities (84) (16)
Deferred revenue (2,302) (2,150)
Net cash (used in) provided by operating activities (742) 2,068
Purchases of property and equipment (3,042) (3,450)
Purchase of marketable securities (19,066) (41,784)
Proceeds from maturities and sales of marketable securities 22,954 22,612
Net cash provided by (used in) investing activities 846 (22,622)
Repurchase of outstanding common stock (4,805) (1,184)
Taxes paid by Company for stock swaps and RSUs (24) (49)
Proceeds from sale of common stock 91 109
Tax benefit from stock-based compensation expense 3,378 1,585
Principal payments on long-term debt (2,330) (1,940)
(Increase) decrease in other assets (57) 24
Payments to minority interest holders (257) (361)
Net cash used in financing activities (4,004) (1,816)
Net decrease in cash and cash equivalents (3,900) (22,370)
Cash and cash equivalents at beginning of period 8,135 27,817
Cash and cash equivalents at end of period 4,235 5,447
Income tax expense not payable 3,378 1,585
Long-term receivable from Monsanto for guaranteed termination fee 400 400
Unrealized gain (loss) from interest rate swap $ 32 $ (152)